Brett Shandler advises clients in the technology and life science sectors on intellectual property, licensing, and commercial contract matters.
Prior to joining Latham, Mr. Shandler acted in patent litigation matters in the technology and life science sectors, including in the defence of high-value royalty and damages claims.
In the technology sphere, Mr. Shandler has a particular interest in IP and antitrust issues arising in the context of standard essential patents (SEP) and fair, reasonable, and non-discriminatory (FRAND) licensing. He also has an interest in the Unified Patent Court scheme and its implications from a licensing and M&A perspective.
Mr. Shandler has been recognized as a Rising Star by Managing IP.